InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by YANCOPOULOS GEORGE, Président et Directeur Scientifique. Insider active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 8 disclosures have been published. Total volume traded: €51.5m. The latest transaction was filed on 22 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
◇
239,063 shares@ €158.69660.052% mcap59.6% of flowCommon StockSEC:0001883850-21-000034
◇
239,063 shares@ €158.69660.052% mcap29.8% of flowCommon StockSEC:0001883850-21-000034:0
▼
773 shares@ €532.53750.0006% mcap0.6% of flowCommon StockSEC:0001708138-21-000055
▼
773 shares@ €532.53750.0006% mcap0.3% of flowCommon StockSEC:0001708138-21-000055:0
▼
50,000 shares@ €506.99070.035% mcap39.8% of flowCommon StockSEC:0001708138-21-000044
▼
50,000 shares@ €506.99070.035% mcap19.9% of flowCommon StockSEC:0001708138-21-000044:0
82,108 shares0Common StockSEC:0001708138-21-000026
82,108 shares0Common StockSEC:0001708138-21-000026:0
8 of 8 declarations
About YANCOPOULOS GEORGE
George Yancopoulos is the President and Chief Scientific Officer at REGENERON PHARMACEUTICALS, INC. He is responsible for the company's scientific direction, overseeing the research and development of new treatments. His expertise in biotechnology and pharmacology is essential in guiding research initiatives. He plays a key role in developing scientific strategies and product innovation.
